Related Experiment Video
Updated: Dec 9, 2025

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
Genome-Wide CRISPR Off-Target DNA Break Detection by the BLISS Method
Roberto Ballarino1, Britta A M Bouwman1, Nicola Crosetto2
1Science for Life Laboratory (SciLifeLab), Research Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Abstract:
Clustered regularly interspaced palindromic repeat (CRISPR) systems are revolutionizing many areas of biology and medicine, where they are increasingly utilized as therapeutic tools for correcting disease-causing mutations. From a clinical perspective, unintended off-target (OT) DNA double-strand break (DSB) induction by CRISPR nucleases represents a major concern. Therefore, in recent years considerable effort has been dedicated to developing methods for assessing the OT activity of CRISPR nucleases, which in turn can be used to guide engineering of nucleases with minimal OT activity. Here we describe a detailed protocol for quantifying OT DSBs genome-wide in cultured cells transfected with CRISPR enzymes, based on the breaks labeling in situ and sequencing (BLISS) method that we have previously developed. CRISPR-BLISS is versatile and scalable, and allows assessment of multiple guide RNAs in different cell types and time points following cell transfection or transduction.
Insights
This study details a method to accurately measure unintended DNA damage from CRISPR gene editing tools. This helps ensure the safety and efficacy of CRISPR therapies by identifying and minimizing off-target effects.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Clustered regularly interspaced palindromic repeat (CRISPR) systems offer powerful therapeutic potential for genetic diseases.
- A significant clinical concern is the induction of unintended off-target (OT) DNA double-strand breaks (DSBs) by CRISPR nucleases.
Purpose of the Study:
- To describe a detailed protocol for quantifying genome-wide OT DSBs induced by CRISPR nucleases.
- To enable the engineering of CRISPR nucleases with minimized OT activity for safer therapeutic applications.
Main Methods:
- The study utilizes the previously developed Breaks Labeling In Situ and Sequencing (BLISS) method.
- CRISPR-BLISS is applied to quantify OT DSBs in cultured cells post-transfection or transduction.
Main Results:
- The CRISPR-BLISS method provides a versatile and scalable approach for assessing CRISPR nuclease activity.
- It allows for the evaluation of multiple guide RNAs across different cell types and time points.
Conclusions:
- CRISPR-BLISS is an effective tool for quantifying genome-wide off-target DNA double-strand breaks.
- This method is crucial for advancing the clinical safety and development of CRISPR-based gene therapies.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
Homologous Recombination
CRISPR

